2010
DOI: 10.1016/j.ijfoodmicro.2010.05.001
|View full text |Cite
|
Sign up to set email alerts
|

Safety assessment and evaluation of probiotic potential of bacteriocinogenic Enterococcus faecium KH 24 strain under in vitro and in vivo conditions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
54
0
2

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 79 publications
(59 citation statements)
references
References 58 publications
3
54
0
2
Order By: Relevance
“…The same results were observed in E. faecium and E. faecium strains after incubation at pH 3.0 (Bhardwaj et al, 2010;Strompfová, Lauková, & Ouwehand, 2004). The Enterococcus strains can maintain difference between environmental and cytoplasmic pH via a unique homeostasis mechanism with a bilayer membrane structure; consequently, these strains can tolerate a wide range of pH (Musikasang, Tani, H-kittikun, & Maneerat, 2009).…”
Section: Discussionsupporting
confidence: 71%
“…The same results were observed in E. faecium and E. faecium strains after incubation at pH 3.0 (Bhardwaj et al, 2010;Strompfová, Lauková, & Ouwehand, 2004). The Enterococcus strains can maintain difference between environmental and cytoplasmic pH via a unique homeostasis mechanism with a bilayer membrane structure; consequently, these strains can tolerate a wide range of pH (Musikasang, Tani, H-kittikun, & Maneerat, 2009).…”
Section: Discussionsupporting
confidence: 71%
“…A recent study demonstrated that the bacteriocin-producing strain Enterococcus faecium KH24 significantly affected the fecal microbiota of mice (3). In this study, mice received 10 8 CFU/day of bacteriocinogenic E. faecium KH24 (Bac ϩ ) and a nonbacteriocinogenic variant (Bac Ϫ ) for a period of 12 days.…”
Section: Bacteriocin Function: An Ecological Perspectivementioning
confidence: 98%
“…Antagonistic activity of the bacteriocin producers against a number of pathogenic or antibiotic-resistant bacterial strains in the gut has been a major focus of gut microbiota studies. Several LAB bacteriocins and/or bacteriocin-producing LAB have been shown to inhibit pathogens such as Listeria monocytogenes [83,84], Clostridium difficile [8587], Staphylococcus aureus [88] and even Salmonella enteritidis [89], Some bacteriocin producers have also been reported to eliminate multidrug- or vancomycin-resistant enterococci [81,90]. Therefore, the production of bacteriocins may contribute to the beneficial activities in the gut.…”
Section: Bacteriocinsmentioning
confidence: 99%